CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL LICENSE AND DEVELOPMENT AGREEMENT by and between...License and Development Agreement • September 1st, 2021 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances) • New York
This LICENSE AND DEVELOPMENT AGREEMENT (the “Agreement”) is entered into as of August 27, 2021 (the “Effective Date”) by and between VORONOI INC., a limited liability corporation organized under the laws of the Republic of Korea having a principal place of business at S 18thF, Songdogwahak-ro 32[IT Center], Yeonsu-gu, Incheon, Korea (including any Affiliates and successor entities) (“Licensor”) and BRICKELL BIOTECH, INC., a Delaware corporation having a principal place of business at 5777 Central Avenue, Boulder, Colorado, USA 80301 (including any Affiliates and successor entities) (“Licensee”). Licensor and Licensee are sometimes referred to individually as a “Party” and collectively as the “Parties”.
